Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001081317 | SCV000562841 | benign | Brugada syndrome 4 | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620685 | SCV000735161 | benign | Cardiovascular phenotype | 2015-08-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV001081317 | SCV000883537 | benign | Brugada syndrome 4 | 2020-05-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001706447 | SCV001892000 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001706447 | SCV005320483 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV001699297 | SCV001918701 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001699297 | SCV001956122 | benign | not specified | no assertion criteria provided | clinical testing |